Celldex Therapeutics, Inc. Q1 FY2025 Earnings Call

Celldex Therapeutics, Inc. (CLDX)

Earnings Call FY2025 Q1 Call date: 2025-05-08 Concluded

Quarter scorecard

Revenue

$695,000

+345.5% YoY

Diluted EPS

$-0.81

Net income

-$53.80M

Grant $645,000

+318.8%

Service $50,000

+2400%